www.fdanews.com/articles/87294-cardiome-astellas-fda-setback-for-heart-drug
CARDIOME/ASTELLAS: FDA SETBACK FOR HEART DRUG
June 2, 2006
The FDA has refused to accept an application for a proposed treatment of atrial fibrillation. The approval of Cardiome's new treatment for atrial fibrillation is set to be delayed by almost a year after the FDA refused to file an application for the drug.
Pharmaceutical Business Review